US Patent Issued to PriZm, The University of Miami, The University of Chicago on Aug. 19 for "Methods for treating allan-herndon-dudley syndrome" (Illinois, Florida, Arizona Inventors)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,390,432, issued on Aug. 19, was assigned to PriZm LLC (Chandler, Ariz.), The University of Miami (Coral Gables, Fla.) and The University of Chicago (Chicago).

"Methods for treating allan-herndon-dudley syndrome" was invented by Samuel Refetoff (Chicago), Roy Weiss (Miami Beach, Fla.) and Khemraj Hirani (Chandler, Ariz.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present subject matter is directed to methods of treating Allan-Herndon-Dudley syndrome comprising administering 3,5-diiodothyropropionic acid (DITPA) to a subject in need thereof, wherein the DITPA administration reduces triiodothyronine ("T3") serum levels to normal, increases T3 brain ...